# C_2016028EN.01000501.xml

| 26.1.2016 | EN | Official Journal of the European Union | C 28/5 |
| --- | --- | --- | --- |

26.1.2016

EN

Official Journal of the European Union

C 28/5

---

Prior notification of a concentration

(Case M.7813 — Sanofi/Google/DMI JV)

(Text with EEA relevance)

(2016/C 28/06)

| 1. | On 19 January 2016, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which Sanofi SA (‘Sanofi’, France) and Google Inc. (‘Google’, United States), the latter through its wholly-owned subsidiary Verily Life Sciences LLC (‘Verily’, United States), acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of a newly created company constituting a joint venture (the ‘JV’), by way of purchase of shares. |
| --- | --- |

1.

On 19 January 2016, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which Sanofi SA (‘Sanofi’, France) and Google Inc. (‘Google’, United States), the latter through its wholly-owned subsidiary Verily Life Sciences LLC (‘Verily’, United States), acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of a newly created company constituting a joint venture (the ‘JV’), by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:






  — | Sanofi is a global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. In particular, Sanofi offers a range of solutions for the treatment of diabetes. |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

Sanofi is a global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. In particular, Sanofi offers a range of solutions for the treatment of diabetes.

| — | Verily was established in order to group together Google’s life sciences related projects. |
| --- | --- |

—

Verily was established in order to group together Google’s life sciences related projects.

| — | The JV will offer services for the management and treatment of diabetes. In addition, the JV may commercialise certain products (such as specialised continuous glucose monitoring devices, insulin pumps and insulin) which can be used alongside the services. |
| --- | --- |

—

The JV will offer services for the management and treatment of diabetes. In addition, the JV may commercialise certain products (such as specialised continuous glucose monitoring devices, insulin pumps and insulin) which can be used alongside the services.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference M.7813 — Sanofi/Google/DMI JV, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference M.7813 — Sanofi/Google/DMI JV, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---